Michael S. Anderson

679 total citations
18 papers, 494 citations indexed

About

Michael S. Anderson is a scholar working on Infectious Diseases, Surgery and Radiological and Ultrasound Technology. According to data from OpenAlex, Michael S. Anderson has authored 18 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 2 papers in Surgery and 2 papers in Radiological and Ultrasound Technology. Recurrent topics in Michael S. Anderson's work include Viral Infections and Outbreaks Research (5 papers), Viral Infections and Vectors (4 papers) and Risk and Safety Analysis (2 papers). Michael S. Anderson is often cited by papers focused on Viral Infections and Outbreaks Research (5 papers), Viral Infections and Vectors (4 papers) and Risk and Safety Analysis (2 papers). Michael S. Anderson collaborates with scholars based in United States and United Kingdom. Michael S. Anderson's co-authors include Andrew V. Schally, James C. Torner, Lawrence H. Phillips, Gary M. Cox, Abba J. Kastin, Nicholas P. Plotnikoff, John F. Wilber, Peter J. Snyder, Cyril Y. Bowers and Paul Schalch and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Michael S. Anderson

17 papers receiving 443 citations

Peers

Michael S. Anderson
Stavroula Veletza Greece
Maria Phylactou United Kingdom
Patricia René France
Virginia Parks United States
Frederick Vogel Germany
Maira Soto United States
Aleksander Keselman United States
Ola Collin Sweden
Amanda Louise Gruver United States
Parul Gupta India
Stavroula Veletza Greece
Michael S. Anderson
Citations per year, relative to Michael S. Anderson Michael S. Anderson (= 1×) peers Stavroula Veletza

Countries citing papers authored by Michael S. Anderson

Since Specialization
Citations

This map shows the geographic impact of Michael S. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Anderson more than expected).

Fields of papers citing papers by Michael S. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Anderson. The network helps show where Michael S. Anderson may publish in the future.

Co-authorship network of co-authors of Michael S. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Anderson. A scholar is included among the top collaborators of Michael S. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Anderson. Michael S. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Anderson, Michael S., et al.. (2023). Case Report: Heterotopic Pancreatic Tissue Leading to Acute on Chronic Cholecystitis. Cureus. 1 indexed citations
3.
Niemuth, Nancy A., et al.. (2023). A Case Study for Critical Reagent Qualification for Ligand Binding Assays Using Equivalence Test Methodology. The AAPS Journal. 25(5). 89–89. 2 indexed citations
4.
House, Robert V., Thomas Broge, Todd J. Suscovich, et al.. (2022). Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics. PLoS ONE. 17(6). e0267796–e0267796. 3 indexed citations
5.
6.
Henning, Lisa N., Kathrin Endt, Robin Steigerwald, Michael S. Anderson, & Ariane Volkmann. (2021). A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge. Frontiers in Immunology. 11. 598847–598847. 7 indexed citations
7.
8.
9.
Grossman, Trudy H., Michael S. Anderson, David D. Christ, et al.. (2017). The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques. Antimicrobial Agents and Chemotherapy. 61(8). 11 indexed citations
10.
Oussedik, Elias, Michael S. Anderson, & Steven R. Feldman. (2017). Risk versus benefit or risk versus risk: Risk aversion in the medical decision making process. Journal of Dermatological Treatment. 28(1). 1–2. 16 indexed citations
11.
Cullen, Laura & Michael S. Anderson. (2005). Human Factors Integration for a New Top Tier COMAH Site. Process Safety and Environmental Protection. 83(2). 101–108. 3 indexed citations
12.
Anderson, Michael S.. (2005). Behavioural Safety and Major Accident Hazards. Process Safety and Environmental Protection. 83(2). 109–116. 35 indexed citations
13.
Forsling, Mary L., et al.. (1996). The effect of oophorectomy and hormone replacement on neurohypophyseal hormone secretion in women. Clinical Endocrinology. 44(1). 39–44. 6 indexed citations
14.
Graczyk, Thaddeus K., M R Cranfield, Ronald Fayer, & Michael S. Anderson. (1996). Viability and infectivity of Cryptosporidium parvum oocysts are retained upon intestinal passage through a refractory avian host. Applied and Environmental Microbiology. 62(9). 3234–3237. 37 indexed citations
15.
Phillips, Lawrence H., James C. Torner, Michael S. Anderson, & Gary M. Cox. (1992). The epidemiology of myasthenia gravis in central and western Virginia. Neurology. 42(10). 1888–1888. 124 indexed citations
16.
Kastin, Abba J., Nicholas P. Plotnikoff, Sharon P. Viosca, Michael S. Anderson, & Andrew V. Schally. (1973). MSH-release inhibiting factors: recent studies.. PubMed. 46(5). 617–22. 10 indexed citations
17.
Plotnikoff, Nicholas P., Abba J. Kastin, Michael S. Anderson, & Andrew V. Schally. (1972). Oxotremorine Antagonism by a Hypothalamic Hormone, Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF). Experimental Biology and Medicine. 140(3). 811–814. 56 indexed citations
18.
Anderson, Michael S., Cyril Y. Bowers, Abba J. Kastin, et al.. (1971). Synthetic Thyrotropin-Releasing Hormone. New England Journal of Medicine. 285(23). 1279–1283. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stavroula Veletza Breakdown of academic impact, for papers by Maria Phylactou Breakdown of academic impact, for papers by Patricia René Breakdown of academic impact, for papers by Virginia Parks Breakdown of academic impact, for papers by Frederick Vogel Breakdown of academic impact, for papers by Maira Soto Breakdown of academic impact, for papers by Aleksander Keselman Breakdown of academic impact, for papers by Ola Collin Breakdown of academic impact, for papers by Amanda Louise Gruver Breakdown of academic impact, for papers by Parul Gupta
Rankless by CCL
2026